Managed Healthcare Executive November 21, 2023
Briana Contreras

Prior to the IRA, there were no limits on beneficiary OOP spending throughout the year. However, by 2025 the IRA will introduce the $2,000 maximum OOP expenses.

The impact of the Inflation Reduction Act‘s (IRA) out-of-pocket cap will mostly affect Non-White Part D beneficiaries, with Black beneficiaries experiencing substantial savings as the highest spenders, according to an analysis shared back in October during the AMCP Nexus conference in Orlando.

Authors of the analysis also found that low-income subsidy (LIS) beneficiaries are anticipated to reach the out-of-pocket (OOP) threshold earlier than their non-LIS counterparts.

Shared as a poster during the conference, the analysis looked at the impact of the IRA’s $2,000 OOP spending cap on Medicare Part D beneficiaries as it...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare, Patient / Consumer
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article